The chemical class identified as C1orf83 Inhibitors comprises a range of compounds selected for their potential to modulate the activity of C1orf83, a protein involved in transcription elongation. This class is not defined by a shared chemical structure but by the shared objective of influencing C1orf83's function within the transcription process. These inhibitors operate through various mechanisms, reflecting the complexity of transcription elongation and the role of C1orf83 in this essential cellular process. The inhibitors in this class include those that can disrupt the interaction of C1orf83 with key components of the transcription machinery, as well as those that influence the broader environment in which C1orf83 operates, such as chromatin structure and transcriptional regulation.
The inhibitors targeting C1orf83 function by interfering with the transcription elongation process at different stages. Some achieve this by hindering the interaction between C1orf83 and RNA Polymerase II, thereby directly impacting the elongation phase of mRNA synthesis. Others work by modulating the chromatin landscape, affecting the accessibility of DNA for transcription, and indirectly influencing the role of C1orf83. Additionally, certain inhibitors in this class focus on altering the phosphorylation status of transcription-related proteins, which is a critical regulatory mechanism in transcription elongation. This approach allows for the indirect modulation of C1orf83's activity by changing the dynamics of transcription initiation and elongation processes. The C1orf83 Inhibitors class represents a strategic approach to manipulating a specific protein's function by intervening in broader biological processes and pathways. This class underscores the intricate relationship between chemical entities and biological systems, showcasing the depth of understanding required to manipulate specific protein functions within complex biological processes. It highlights the potential of targeted molecular intervention in studying and influencing key aspects of cellular function, particularly transcription, a fundamental process critical to all cellular activities. By focusing on the modulation of transcription elongation, this class of inhibitors opens up avenues for research into the mechanisms of gene expression regulation and the role of specific proteins like C1orf83 in these processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Alpha-Amanitin inhibits RNA Polymerase II, potentially disrupting the transcription elongation process in which C1orf83 is involved by hindering the elongation phase of mRNA synthesis. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB inhibits transcription elongation by affecting the activity of RNA Polymerase II, which could indirectly impact C1orf83's function in facilitating transcription elongation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide inhibits the transcriptional activity by affecting RNA Polymerase II, potentially disrupting C1orf83's role in the transcription elongation process. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $311.00 | ||
Flavopiridol Hydrochloride inhibits CDK9, a key regulator of transcription elongation, potentially affecting C1orf83's function by altering the phosphorylation status of RNA Polymerase II. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Rocaglamide inhibits translation initiation and, by altering protein synthesis, might indirectly affect C1orf83's function in transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, potentially inhibiting transcription processes by blocking RNA Polymerase movement, which would affect C1orf83's role in transcription elongation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, can affect chromatin structure, potentially impacting C1orf83's function in transcription elongation by altering DNA accessibility. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
MS-275 targets chromatin readers, which might influence transcription elongation activities involving C1orf83 by altering chromatin dynamics. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid, by inhibiting histone deacetylase, can affect chromatin structure and indirectly impact C1orf83's role in transcription elongation. | ||||||